Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

NCT04401748

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Duplicate_Providence Medical Foundation /ID# 222633 Fullerton, California, United States
  • University of California, Los Angeles /ID# 221760 Los Angeles, California, United States
  • Torrance Memorial Physician Network Cancer Care /ID# 222702 Torrance, California, United States
  • PIH Health Whittier Hospital /ID# 222647 Whittier, California, United States
View all 220 locations
View Trial Details
Active, Not Recruiting

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

NCT03821610

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Heart of England Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Birmingham Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol Nhs Foundation Trust Bristol, United Kingdom
  • Cambridge University Hospitals Nhs Foundation Trust Cambridge, United Kingdom
View all 22 locations
View Trial Details
Active, Not Recruiting

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details

Related conditions